In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Arrogate Impresses at Santa Anita
- Far From Over Victorious in Return
- How a Sire Line Develops
- Phantom Dollars Flood Track's Double Pool
- Too Early to Gauge 'Brexit' Effect on Sales
- Magee Clinches Training Title at Pimlico
- Fairplex, Santa Anita House Evacuated Horses
- Mohaymen Back to Work in New York
- Exclusive Contest: Name the White-Headed Foal
- Weather Impacts Churchill June 23 Program